Novartis AG (SWX:NOVN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
126.60
-0.18 (-0.14%)
Jul 31, 2026, 5:30 PM CET

Novartis AG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12,75713,98411,94114,8506,95524,021
Depreciation & Amortization
4,8234,7444,5998,1834,9944,949
Loss (Gain) From Sale of Assets
-245116-74-180-308-646
Asset Writedown & Restructuring Costs
7205811,470941,711648
Loss (Gain) From Sale of Investments
-101-5045106260-14,638
Loss (Gain) on Equity Investments
1112381311-214
Stock-Based Compensation
1,1371,0961,044865791700
Other Operating Activities
1,5821,721369-7,808195-607
Change in Accounts Receivable
-674-1,124-931-1,504-397-352
Change in Inventory
-4234-225-546-560-102
Change in Accounts Payable
-195-273-105479-181-111
Change in Other Net Operating Assets
-1,380-1,697-552-332-432-283
Operating Cash Flow
18,39319,14417,61914,45814,23615,071
Operating Cash Flow Growth
-11.52%8.65%21.86%1.56%-5.54%10.41%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,630-1,548-1,366-1,060-916-1,066
Sale of Property, Plant & Equipment
331386237158211
Cash Acquisitions
-15,676-2,916-4,018-3,561-832-259
Divestitures
-13-881073-854
Sale (Purchase) of Intangibles
-1,619-2,188-2,368262-1,153-804
Investment in Securities
9031,8745310,8494,6566,816
Other Investing Activities
197-24-7-1,134-437-744
Investing Cash Flow
-17,805-4,877-7,5135,5961,4684,208

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5958546252-
Long-Term Debt Issued
-6,0986,143---
Total Debt Issued
18,5526,1037,101546252-
Short-Term Debt Repaid
---289---3,547
Long-Term Debt Repaid
--3,673-2,422-2,481-2,837-2,440
Total Debt Repaid
-2,104-3,673-2,711-2,481-2,837-5,987
Net Debt Issued (Repaid)
16,4482,4304,390-1,935-2,585-5,987
Issuance of Common Stock
20273015310053
Repurchase of Common Stock
-6,856-9,212-8,331-8,719-10,652-3,057
Common Dividends Paid
-9,068-7,818-7,624-7,255-7,506-7,368
Other Financing Activities
-91-294-2073,4788195
Financing Cash Flow
453-14,867-11,742-14,278-20,562-16,264

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-81576-298100-32-266
Net Cash Flow
960-24-1,9345,876-4,8902,749

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
16,76317,59616,25313,39813,32014,005
Free Cash Flow Growth
-13.25%8.26%21.31%0.59%-4.89%13.17%
Free Cash Flow Margin
29.57%31.05%31.42%28.71%30.65%31.85%
Free Cash Flow Per Share
8.709.007.996.406.066.20
Levered Free Cash Flow
11,90012,11512,03813,6767,31111,774
Unlevered Free Cash Flow
12,76912,83012,66714,2107,81112,266

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,041981855751667643
Cash Income Tax Paid
2,5322,5622,2582,7871,7021,856
Change in Working Capital
-2,291-3,060-1,813-1,903-1,570-848